Lyndsay Rhodes

(* denotes undergraduate author)

Xylia J. Horgan*, Hannah Tatum*, Emily Brannan*, Daniel H. Paull, and Lyndsay V. Rhodes, Resveratrol analogues surprisingly effective against triple-negative breast cancer, independent of ER?, Oncology Reports 2019, 41(6): 3517-3526. PMID: 31002359

Jesse Champer*, Sarah Cushion*, Sierra King*, Carlee Rushlow*, Bertin Cenatus*, and Lyndsay V. Rhodes, Effects of Stilbene Compounds on Danio rerio Mortality and Embryonic Development, Eastern Biologist 2019, Special Issue 1 (Zebrafish as a Model System for Research and Teaching): 90-100.

Margarite Matossian, Hope Burks, Steven Elliott, Van T. Hoang, Annie C. Bowles, Rachel A. Sabol, Bahia Wahba, Mohammed E. Abazeed, Bruce A. Bunnell, Krzysztof Moroz, Lucio Miele, Lyndsay V. Rhodes, Steven D. Jones, Elizabeth C. Martin, Bridgette M. Collins-Burow, Matthew E. Burow. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model, BMC Cancer 2019, 19(1): 205-221. PMID: 30845999

Margarite D. Matossian, Hope E. Burks, Annie C. Bowles, Steven Elliott, Van T. Barnes, Rachel A. Sabol, Nicholas Pashos, Benjamen O'Donnell, Kristin Miller, Bahia Wahba, Bruce A. Bunnell, Krzysztof Moroz, Arnold H. Zea, Steven D. Jones, Adam I. Riker, Lyndsay V Rhodes, Elizabeth Martin, Lucio Miele, Matthew E. Burow, and Bridgette M. Collins-Burow. A novel patient-derived xenograft model for claudin-low triple-negative breast cancer, Breast Cancer Research and Treatment 2018, 169(2):381-390. PMID: 29392581

Adrienne K. Conger, Elizabeth C. Martin, Thomas J. Yan, Lyndsay V. Rhodes, Van T. Hoang, Jacqueline La, Muralidharan Anbalagan, Hope E. Burks, Brian G. Rowan, Kenneth P. Nephew, Bridgette M. Collins-Burow, and Matthew E. Burow. Argonaute 2 expression correlates with a luminal B breast cancer subtype and induces estrogen receptor alpha isoform variation. Non-coding RNA2016, 2(3): 8.

Lyndsay V. Rhodes^§, Elizabeth C. Martin^§, H. Chris Segar, David F. B. Miller, Aaron Buechlein, Doug Rusch, Kenneth P. Nephew, Matthew E. Burow, Bridgette M. Collins-Burow. Dual regulation by microRNA-200b-3p and microRNA-200b*-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Oncotarget2015,6(18):16638-52. (^§ co-first author) PMID: 26062653

Lyndsay V. Rhodes, Chandra R. Tate, Van T. Hoang, Hope E. Burks, Diari Gilliam*, Elizabeth C. Martin, Steven Elliott, David B. Miller, Aaron Buechlein, Douglas B. Rusch, Haixu Tang, Kenneth P. Nephew, Matthew E. Burow, Bridget M. Collins-Burow. Regulation of triple-negative breast cancer cell metastasis by the tumor suppressor Liver Kinase B1. Oncogenesis2015, 4: e168. PMID: 26436950

Amy L. Strong, Jason F. Ohlstein, Brandi A. Biagas, Lyndsay V. Rhodes, Dorothy T. Pei, Alan Tucker, Claire Llamas, Annie C. Bowles, Maria F. Dutreil, Shijia Zhang, Jeffrey M. Gimble, Matthew E. Burow, Bruce A. Bunnell. Leptin Produced by Obese ASCs Enhances Proliferation and Metastasis of Estrogen Receptor Positive Breast Cancers. Breast Cancer Research 2015, 17:112. PMID: 26286584

Lyndsay V. Rhodes^§, Elizabeth C. Martin^§, H. Chris Segar, David F. B. Miller, Aaron Buechlein, Doug Rusch, Kenneth P. Nephew, Matthew E. Burow, Bridgette M. Collins-Burow. Dual regulation by microRNA-200b-3p and microRNA-200b*-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Oncotarget 2015, 6(18):16638-52. PMID: 26062653 (^§ denotes co-first author)

Lyndsay V. Rhodes, Chandra R. Tate, Van T. Hoang, Hope E. Burks, Diari Gilliam*, Elizabeth C. Martin, Steven Elliott, David B. Miller, Aaron Buechlein, Douglas B. Rusch, Haixu Tang, Kenneth P. Nephew, Matthew E. Burow, Bridget M. Collins-Burow. Regulation of triple-negative breast cancer cell metastasis by the tumor suppressor Liver Kinase B1. Oncogenesis 2015, 4, e168. PMID: 26436950

 

Melissa R. Bratton, Elizabeth C. Martin, Steven Elliott, Lyndsay V. Rhodes, Bridgette M. Collins-Burow, John A. McLachlan, Thomas E. Wiese, Stephen M. Boue, Matthew E. Burow. Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer. J Steroid Biochem Mol Biol 2015, 150:17-23. PMID: 25771071

 

Yan Zhuang, Hong T Nguyen, Matthew E Burow, Ying Zhuo, Samir S El?Dahr, Xiao Yao, Subing Cao, Erik K Flemington, Kenneth P Nephew, Fang Fang, Bridgette Collins?Burow, Lyndsay V Rhodes, Qiang Yu, Janarthanan Jayawickramarajah, Bin Shan. Elevated expression of long intergenic non?coding RNA HOTAIR in a basal?like variant of MCF?7 breast cancer cells. Molecular Carcinogenesis. 2014, October 18. IN PRESS. PMID: 25328122

 

Elizabeth C. Martin, Lyndsay V. Rhodes, Steven Elliott, Adrienne E. Krebs, Kenneth P. Nephew, Erik K. Flemington, Bridgette M. Collins-Burow, Matthew E. Burow. microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity. Molecular Cancer 2014, 13(1): 229. PMID: 25283550

Lyndsay V. Rhodes, Chandra R. Tata, H. Chris Segar, Hope E. Burks, Theresa B. Phamduy, Steven Elliott, Diari Gilliam*, F. Nell Pounder, Muralidharan Anbalagan, Douglas B. Chrisey, Brian G. Rowan, Matthew E. Burow, and Bridgette M. Collins-Burow. Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators. Breast Cancer Research and Treatment 2014, 145(3): 593-604. PMID: 24810497

 

Elizabeth C. Martin, Adrienne Krebs, Lyndsay V. Rhodes, Bridgette M. Collins-Burow, Matthew E. Burow. Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor alpha Isoform Variation in the MCF-7 Breast Cancer Cell Line. Endocrine-Related Cancer. Accepted pending revisions Febuary 18, 2014.

 

Amy L. Strong, Thomas A. Strong, Lyndsay V. Rhodes, Julie A. Semon, Xiujuan Zhang, Zhenzhen Shi, Shijia Zhang, Jeffrey M. Gimble, Matthew E. Burow and Bruce A. Bunnell. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Research 2013, 15(5): R102. Highly Accessed. PMID: 24176089

 

David F.B. Miller, Pearlly S. Yan, Aaron Buechlien, Benjamin A. Rodriguez, Ayse S. Yilmaz, Shokhi Goel, Hai Lin, Bridgette Collins-Burow, Lyndsay V. Rhodes, Chris Braun, Sunila Pradeep, Rajesha Rupaimoole, Mehmet Dalkilic, Anil K. Sood, Matthew E. Burow, Haixu Tang, Tim H. Huang, Yunlong Liu, Douglas B. Rusch, and Kenneth P. Nephew. A new method for stranded whole transcriptome RNA-seq. Methods 2013, 63(2): 126-34. PMID: 23557989

 

James W. Antoon, Elizabeth C. Martin, Rongye Lai, Virgilo A. Salvo, Yan Tang, Ashley M. Nitzchke Steven Elliott, Seung Yoon Nam, Wei Xiong, Lyndsay V. Rhodes, Bridgette Collins-Burow, Odile David, Guandi Wang, Bin Shan, Barbara S. Beckman, Kenneth P. Nephew, and Matthew E. Burow. MEK5/Erk5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis. PLoS One 2013, 8(8): e69291. PMID: 23950888

 

KiTani P Johnson, Letitia A. Yearby, Diana Stoute, Matthew E. Burow, Lyndsay V. Rhodes, Marian Gray, Patrick Carriere, Syreeta L. Tilghman, John A. McLachlan, Josiah Ochieng, Leonard Jack, and Kathleen Kennedy. In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models. Journal of Health Care for the Poor and Underserved. 2013, 24(1): 104. PMID: 23395947

 

James W. Antoon, Ashley M. Nitzchke, Elizabeth C. Martin, Lyndsay V. Rhodes, Seungyoon Nam, Scott Wadsworth, Virgilio A. Salvo, Steven Elliott, Bridgette Collins-Burow, Kenneth P. Nephew, and Matthew E. Burow. Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition. International Journal of Oncology. 2013, 42(4): 1139. PMID: 23403951

 

Syreeta L. Tilghman, Lyndsay V. Rhodes, Melyssa R. Bratton, Patrick Carriere, Lynez C. Preyan, Stephen M. Boue, John McLachlan, and Matthew E. Burow. Phytoalexins, miRNAs and breast cancer: a review of phytochemical-mediated miRNA regulation in breast cancer. Journal of Health Care for the Poor and Underserved. 2013, 24(1): 36. PMID: 23395943

 

Elizabeth C. Martin, Melyssa R. Bratton, Yun Zhu, Lyndsay V. Rhodes, Syreeta L. Tilghman, Bridgette M. Collins-Burow, and Matthew E. Burow. Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line. PLoS One. 2012, 7(11):e49067. PMID: 23226206.

 

Elizabeth C. Martin, Steven Elliott, Lyndsay V. Rhodes, James W. Antoon, C. Fewell, Yun Zhu, Jennifer L. Driver, Mona Jodari-Karimi, CW Taylor, Erik K. Flemington, Barbara S. Beckman, Bridgette M. Collins-Burow, and Matthew E. Burow. Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells. Mol Carcinog. 2012, Epub ahead of print. PMID: 22911661.

 

James W. Antoon, R. Lai, Amanda P. Struckhoff, Ashley S. Nitschke, Steven Elliott, Lyndsay V. Rhodes, S.Y. Nam, Virgilio A. Salvo, Bin Shan, Barbara S. Beckman, Kenneth P. Nephew, and Matthew E. Burow. Altered death receptor signaling promotes epithelial-to-mesenchymal transistion and acquired chemoresistance. Sci Rep. 2012, 2: 539. PMID: 22844580.

 

Chandra R. Tate^§, Lyndsay V. Rhodes^§, H. Chris Segar, Jennifer L. Driver, F. Nell Pounder, Matthew E. Burow, and Bridgette M. Collins-Burow. Targeting triple-negative breast cancer cells with the HDAC inhibitor Panobinostat. Breast Cancer Research, 2012, 14 (3): R79. Highly Accessed. PMID: 22613095. (^§ denotes co-first author)

 

C. Zhou, Q. Zhong, Lyndsay V. Rhodes, I. Townley, Melyssa R. Bratton, Q. Zhang, Elizabeth C. Martin, Steven Elliotte, Bridgette M. Collins-Burow, Matthew E. Burow, and Guangdi Wang. Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Research, 2012, 14 (2): R45. Highly Accessed. PMID: 22417809.

 

Syreeta L. Tilghman, Melyssa R. Bratton, H. Chris Segar, Elizabeth C. Martin, Lyndsay V. Rhodes, Meng Li, John A. McLachlan, Thomas E. Wiese, Kenneth P. Nephew, and Matthew E. Burow. Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS ONE, 2012, 7 (3): e32754. PMID: 22403704.

 

Charles E. Wood, Stephen M. Boue, Bridgette M. Collins-Burow, Lyndsay V. Rhodes, Thomas C. Register, J. Mark Cline, Fitriya N. Dewi, and Matthew E. Burow. Glyceollin-elicited soy protein consumption induces distinct transcriptional effects compared to standard soy protein. Journal of Agricultural and Food Chemistry, 2012, 60 (1): 81-86. PMID: 22126086.

Lyndsay V. Rhodes, Syreeta L. Tilghman, Stephen M. Boue, Shuchun Wang, Hafez Khalili, Shannon E. Muir, Melyssa R. Bratton, Qiang Zhang, Guangdi Wang, Matthew E. Burow, Bridgette M. Collins-Burow. Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer. Oncology Letters, 2012, 3 (1): 163-171. PMID: 22740874.

 

Lyndsay V. Rhodes, Ashley M. Nitschke, H. Chris Segar, Elizabeth C. Martin, Jenifer L. Driver, Steven Elliot, Seung Yoon Nam, Meng Li, Keneth P. Nephew, Matthew E. Burow, and Bridgete M. Collins-Burow.  The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncology Reports, 2012, 27: 10-16. PMID:21971930.

Lyndsay V. Rhodes, Melyssa R. Bratton, Yun Zhu, Syreeta L. Tilghman, Shannon E. Muir, Virgilio A. Salvo, Chandra R. Tate, Steven Elliott, Kenneth P. Nephew, Bridgette M. Collins-Burow, Matthew E. Burow. Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER?)-positive breast cancer cells. Experimental Cell Research, 2011, 317 (18): 2573-81. Highly Accessed. PMID: 21906588.

Lyndsay V. Rhodes, Sarah P. Short, Nicole Neel, Virgilio A. Salvo, Yun Zhu, Steven Elliott, Yongkun Wei, Dihua Yu, Menghong Sun, Shannon E. Muir, Juan P. Fonseca, Melyssa R. Bratton, Chris Segar, Syreeta L. Tilghman, Tammy Sobolik-Delmaire, Linda W. Horton, Snjezana Zaja-Milatovic, Bridgette M. Collins-Burow, Scott Wadsworth, Barbara S. Beckman, Charles E. Wood, Suzanne A. Fuqua, Kenneth P. Nephew, Paul Dent, Rebecca A. Worthylake, Tyler J. Curiel, Mien-Chie Hung, Ann Richmond, and Matthew E. Burow. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Research, 2011, 71 (2): 603-13. PMID: 21123450.

 

James W. Antoon, William D. Meacham, Melyssa R. Bratton, Evelyn M. Slaughter*, Lyndsay V. Rhodes, Hasina B. Ashe, Thomas E. Wiese, Matthew E. Burow, and Barbara S. Beckman. Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer. Journal of Molecular Endocrinology. 2011, 46 (3): 205-16. PMID: 21321095.

 

Lyndsay V. Rhodes, James W. Antoon, Shannon E. Muir, Steven Elliott, Barbara S. Beckman, and Matthew E. Burow. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk. Molecular Cancer, 2010, 9: 295-310. Highly Accessed. PMID: 21087507.

James W. Antoon, Martin D. White, Evelyn M. Slaughter*, Shannon E. Muir, Lyndsay V. Rhodes, William D. Meacham, Steven Elliott, H.B. Ashe, Thomas E. Wiese, Charles D. Smith, Matthew E. Burow, Barbara S. Beckman.  Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.  Endocrinology. 2010, 151 (11): 5124-35. PMID: 20861237.

 

Quan Jiang, Florastina Payton-Stewart, Steven Elliott, Jennifer Driver, Lyndsay V. Rhodes, Qiang Zhang, Shilong Zheng, Deepak Bhatnagar, Stephen M. Boue, Bridgette M. Collins-Burow, Jayalakshmi Sridhar, Cheryl Stevens, John A. McLachlan, Thomas E. Wiese, Matthew E. Burow, and Guangdi Wang.  Effect of 7-O Substitutions on Estrogenic and Antiestrogenic Activities of Daidzein Analogues in MCF-7 Breast Cancer Cells. Journal of Medicinal Chemistry. 2010, 53 (16): 6153-63. 20669983.

 

Lyndsay V. Rhodes and Matthew E. Burow. Human  mesenchymal stem cells as mediators of breast carcinoma tumorigenesis and progression. TheScientificWorldJOURNAL. 2010, 10: 1084-1087. PMID: 20563531.

 

Lyndsay V. Rhodes, Shannon E. Muir, Steven Elliott, Lori M. Guillot, James W. Antoon, Patrice Penfornis, Syreeta L. Tilghman, Vergilio A. Salvo, Juan P. Fonseca, Michelle R. Lacey, John A. McLachlan, Brian G. Rowan, Radhika Pochampally, and Matthew E. Burow. Adult human mesenchymal stem cells enhance breast carcinoma tumorigenesis and progression to hormone independence. Breast Cancer Research and Treatment. 2010; 121 (2): 293-300. PMID: 19597705.

 

Amanda P. Struckhoff, Jason R. Vitko, Manish K. Rana, Carter T. Davis, Kamau E. Foderingham, Chi-Hsin Liu, Lyndsay Vanhoy-Rhodes, Steven Elliot, Yun Zhu, Matt E. Burow, and Rebecca A. Worthylake. Dynamic regulation of ROCK controls CXCR4-driven tumor cell adhesion events. Journal of Cell Science. 2010; 123 (Pt3): 401-12. PMID: 20053635.

 

M. Carla Zimmermann, Syreeta L. Tilghman, Stephen M. Boué, Virgilio A. Salvo, Steven Elliott, K.Y. Williams, Elena V. Skripnikova, Hasina Ashe, Florastina Payton-Stewart, Lyndsay Vanhoy-Rhodes, Juan Pablo Fonseca, Cynthia Corbitt, Bridgette M. Collins-Burow, Melanie H. Howell, Michelle Lacey, Betty Y. Shih, Carol Carter-Wientjes, Thomas E. Cleveland, John A. McLachlan, Thomas E. Wiese, Barbara S. Beckman, Matthew E. Burow. Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. Journal of Pharmacology and Experimental Therapeutics. 2010; 332 (1): 35-45. PMID: 19797619.

 

Erica Nierth-Simpson, Melvenia M. Martin, Tung-Chin Chiang, Lilia I. Melnik, Lyndsay V. Rhodes, Shannon E. Muir, Matthew E. Burow, and John A. McLachlan. Human uterine smooth muscle and fibroid cells differ in their rapid estrogen signaling: implications for proliferation. Endocrinology. 2009; 150 (5): 2436-2445. PMID: 19179429.

 

Bich N. Duong, Steven Elliott, Daniel E. Frigo, Lilia I. Melnik, Lyndsay Vanhoy, Suzanne Tomchuck, Helena P. Lebeau, Odile David, Barbara S. Beckman, Jawed Alam, Melyssa R. Bratton, John A. McLachlan, Matthew E. Burow. AKT regulation of ER-beta transcriptional activity in breast cancer. Cancer Research. 2006; 66 (17): 8373-8381. PMID: 16951146.